Nanoparticles for transcutaneous vaccination
Open Access
- 19 August 2011
- journal article
- review article
- Published by Wiley in Microbial Biotechnology
- Vol. 5 (2) , 156-167
Abstract
Summary: The living epidermis and dermis are rich in antigen presenting cells (APCs). Their activation can elicit a strong humoral and cellular immune response as well as mucosal immunity. Therefore, the skin is a very attractive site for vaccination, and an intradermal application of antigen may be much more effective than a subcutaneous or intramuscular injection. However, the stratum corneum (SC) is a most effective barrier against the invasion of topically applied vaccines. Products which have reached the stage of clinical testing, avoid this problem by injecting the nano‐vaccine intradermally or by employing a barrier disrupting method and applying the vaccine to a relatively large skin area. Needle‐free vaccination is desirable from a number of aspects: ease of application, improved patient acceptance and less risk of infection among them. Nanocarriers can be designed in a way that they can overcome the SC. Also incorporation into nanocarriers protects instable antigen from degradation, improves uptake and processing by APCs, and facilitates endosomal escape and nuclear delivery of DNA vaccines. In addition, sustained release systems may build a depot in the tissue gradually releasing antigen which may avoid booster doses. Therefore, nanoformulations of vaccines for transcutaneous immunization are currently a very dynamic field of research. Among the huge variety of nanocarrier systems that are investigated hopes lie on ultra‐flexible liposomes, superfine rigid nanoparticles and nanocarriers, which are taken up by hair follicles. The potential and pitfalls associated with these three classes of carriers will be discussed.Keywords
This publication has 106 references indexed in Scilit:
- LC/MS analysis of stratum corneum lipids: ceramide profiling and discoveryJournal of Lipid Research, 2011
- The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skinJournal of Pharmacy and Pharmacology, 2011
- Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfateBiomaterials, 2011
- Co-administration of protein drugs with gold nanoparticles to enable percutaneous deliveryBiomaterials, 2010
- Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: Comparative in vitro studies with full-thickness and split-thickness pig and human skinJournal of Controlled Release, 2010
- Adjuvanted Influenza Vaccine Administered Intradermally Elicits Robust Long-Term Immune Responses that Confer Protection from Lethal ChallengePLOS ONE, 2010
- Gastric MALT lymphoma: a model of chronic inflammation-induced tumor developmentNature Reviews Gastroenterology & Hepatology, 2010
- External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriersJournal of Experimental Medicine, 2009
- Effects of Chemical Enhancers on Human Epidermal Membrane: Structure-Enhancement Relationship Based on Maximum Enhancement (Emax)Journal of Pharmaceutical Sciences, 2009
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002